Bay Colony Advisory Group, Inc D Astrazeneca PLC Transaction History
Bay Colony Advisory Group, Inc D
- $643 Million
- Q4 2024
A detailed history of Bay Colony Advisory Group, Inc D transactions in Astrazeneca PLC stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 19,466 shares of AZN stock, worth $1.45 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
19,466
Previous 21,581
9.8%
Holding current value
$1.45 Million
Previous $1.68 Million
24.15%
% of portfolio
0.2%
Previous 0.26%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,355Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.5 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.06 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.8 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.76 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.79 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $231B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...